Publicly Traded Cannabis Stock News

GW Pharma Phase 3 Data Due Soon

The Financial Times shared a great history of the ups and downs  of GW Pharma (NASDAQ: GWPH), which will soon report the results of the first of four Phase...
- February 1st, 2016 at 9:42 am

OrganiGram Q1 Sales Break $1mm and Grow 52% from Prior Quarter

OrganiGram: Q1 Financials and Director Appointment MONCTON, NEW BRUNSWICK–(Marketwired – Jan. 29, 2016) – OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) is pleased to announce its financial results for the three...
- January 29th, 2016 at 4:36 pm

Mettrum Second to Market with Cannabis Oils

Mettrum Health Corp. Launches Premium Cannabis Oils Product Line Variety of THC and CBD oils addresses demand for alternative cannabis consumption options TORONTO, Jan. 26, 2016 /CNW/ – Mettrum Health...
- January 26th, 2016 at 3:04 pm

Aphria Sales More than Double From Q1

Aphria Reports Results for Fiscal Q2 2016 Quarterly Revenue Over $2 Million With Adjusted Gross Margin of 68.6% LEAMINGTON, ONTARIO–(Marketwired – Jan. 18, 2016) – Aphria Inc. (“Aphria” or...
- January 18th, 2016 at 8:49 am

Canopy Growth Could Create Cannabis Chocolate Bars

Tweed, the flagship brand of Canopy Growth, operates out of a former Hershey factory in Ontario, and, with changing laws, CEO Bruce Linton hopes that the company could come...
- January 9th, 2016 at 8:00 am

Cannabis Industry Sparks Investor Interest

Sacramento Bee reporter Peter Hecht explores the emergence of the cannabis industry, which is drawing investors like cannabis-industry focused Poseidon Asset Management and Privateer Holdings but also more diversified firms including...
- January 3rd, 2016 at 6:38 am

Canadian Cannabis Producer Aurora Achieves High Yields

Aurora Cannabis is the first approved licensed producer of cannabis in Alberta and recently won its license to sell after being approved to cultivate in February. The technologically advanced...
- January 2nd, 2016 at 9:13 am

Canadian Cannabis Industry is Valued Less than Biotech GW Pharma

Alan Brochstein published an article on the publicly-traded Canadian cannabis stocks, including Aphria, Aurora Cannabis, Canopy Growth, Emerald Health, Mettrum, OrganiGram, PharmaCan Capital and Supreme Pharma. The article, which is...
- December 28th, 2015 at 11:47 am